ICON plc Schedules First Quarter 2024 Earnings Conference Call Read more about ICON plc Schedules First Quarter 2024 Earnings Conference Call
ICON plc to Present at Upcoming Investor Conferences Read more about ICON plc to Present at Upcoming Investor Conferences
ICON Reports Fourth Quarter and Full Year 2023 Results Read more about ICON Reports Fourth Quarter and Full Year 2023 Results
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call Read more about ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment Read more about New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
ICON Issues Financial Guidance for Full Year 2024 Read more about ICON Issues Financial Guidance for Full Year 2024
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON Read more about Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference Read more about ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023 Read more about ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023
ICON Secures Upgraded Credit Rating from Moody’s Investors Service Read more about ICON Secures Upgraded Credit Rating from Moody’s Investors Service
